CannaVEST Corp Share Price OTC Bulletin Board
Equities
US1376531018
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
05-14 | CV Sciences Seeks M&A Opportunities | CI |
05-14 | Transcript : CV Sciences, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Sales 2022 | 16.2M 1.27B | Sales 2023 | 16M 1.26B | Capitalization | 5.47M 429M |
---|---|---|---|---|---|
Net income 2022 | -9M -706M | Net income 2023 | 3M 235M | EV / Sales 2022 | 0.36 x |
Net Debt 2022 | 917K 71.97M | Net cash position 2023 | 875K 68.68M | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-0.44
x | P/E ratio 2023 |
1.77
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
Latest transcript on CannaVEST Corp
Managers | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 15/06/14 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 25/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 15/06/14 |
Jamie Corroon
BRD | Director/Board Member | 54 | 20/07/22 |
William McCorkle
BRD | Director/Board Member | 56 | 20/10/22 |
1st Jan change | Capi. | |
---|---|---|
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |